EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer

Ronald Anderson iD, Bernardo L Rapoport iD, Helen C Steel iD, Annette J Theron iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241511927 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ronald Anderson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Africa. Hauptthemen laut MEDLINE: Cell-Derived Microparticles, Thrombosis, Lung Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aside from their key protective roles in hemostasis and innate immunity, platelets are now recognized as having multifaceted, adverse roles in the pathogenesis, progression and outcome of many types of human malignancy. The most consistent and compelling evidence in this context has been derived from the notable association of elevated circulating platelet counts with the onset and prognosis of various human malignancies, particularly lung cancer, which represents the primary focus of the current review. Key topics include an overview of the association of lung cancer with the circulating platelet count, as well as the mechanisms of platelet-mediated, pro-tumorigenic immunosuppression, particularly the role of transforming growth factor beta 1. These issues are followed by a discussion regarding the pro-tumorigenic role of platelet-derived microparticles (PMPs), the most abundant type of microparticles (MPs) in human blood. In this context, the presence of increased levels of PMPs in the blood of lung cancer patients has been associated with tumor growth, invasion, angiogenesis and metastasis, which correlate with disease progression and decreased survival times. The final section of the review addresses, firstly, the role of cancer-related platelet activation and thrombosis in the pathogenesis of secondary cardiovascular disorders and the associated mortality, particularly in lung cancer, which is second only to disease progression; secondly, the review addresses the potential role of antiplatelet agents in the adjunctive therapy of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell-Derived MicroparticlesThrombosisLung NeoplasmsHumansBlood PlateletsCarcinogenesisDisease Progression

Stichwörter der Autor:innen

immunosuppressionlung cancerlung-cancer-associated thrombosisplatelet factor 4platelet-derived vesiclesplateletstissue factortransforming growth factor beta 1

Autor:innen und Institutionen

  • Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Africa.
  • The Medical Oncology Centre of Rosebank, Johannesburg 2196, South Africa.

ORCID-Profile: Ronald Anderson, Bernardo L Rapoport, Helen C Steel, Annette J Theron

Zitieren

APA

Anderson, R., Rapoport, B. L., Steel, H. C., & Theron, A. J. (2023). Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241511927

Vancouver

Anderson R, Rapoport BL, Steel HC, Theron AJ. Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241511927

BibTeX
@article{Anderson2023,
  author = {Anderson, Ronald and Rapoport, Bernardo L and Steel, Helen C and Theron, Annette J},
  title = {Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241511927}
}
Kostenlos starten →